AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
AIM Vaccine Co., Ltd. has reported a slight decrease in revenue and a significant reduction in gross profit for the first half of 2024, with a notable improvement in lowering its loss attributable to owners by 44.42% compared to the same period in 2023. The financial results indicate a tightening in overall operational expenses despite a challenging period.
For further insights into HK:6660 stock, check out TipRanks’ Stock Analysis page.